
|Podcasts|March 5, 2021
Exploring the evolution of interventional glaucoma
Author(s)Alex Delaney-Gesing
Advertisement
Sahar Bedrood, MD, PhD, glaucoma and cataract specialist at Acuity Eye Group (Pasadena, CA), clinical assistant professor at USC Roski Eye Institute, shares her clinical perspective on the evolution of interventional glaucoma, including the shift in standard treatment procedures and why taking an active approach to treating patients is key for success.
Advertisement
Latest CME
Advertisement
Advertisement
Trending on Ophthalmology Times - Clinical Insights for Eye Specialists
1
DSLT for glaucoma and ocular hypertension: Real-world outcomes in 218 eyes
2
First patient dosed in phase 3 pivotal cohort of LIGHTHOUSE trial evaluating ATSN-201 for X-linked retinoschisis
3
ARPA-H funds tear-duct biosensor system for dry eye, systemic disease
4
Memento Medicines launches with $93 million Series A to advance Tie2-activating bispecific for retinal disease
5























